Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

AMGNAmgen Inc.

Healthcare·Drug Manufacturers—General·NASDAQ·Mkt cap $150.00B
$360.47
-$2.90 (-0.80%) today
IEX feed · not consolidated
Last updated Jul 14, 10:10 AM
63/100 Opportunity
27Risk
59Momentum
52Pullback
65Quality
68Valuation
93Trend
Price & History (up to 5 years)
2025-09-11 → 2026-09-11
Low 263.96— support · — resistanceHigh 443.94
Technical Indicators
RSI (14)55.5
MACD hist-0.07
ATR (14)8.04
SMA 20356.72
SMA 50343.48
SMA 200334.33
Rel volume0.7x
Boll upper375.76
Boll lower337.67
52w high388.21
52w low264.10
5y high388.21
5y low172.56
Hist. vol27%
Max drawdown-17%
Long-Term UptrendNeutral MomentumWait for ConfirmationEntry: Wait for Breakout Confirmation
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Amgen Inc. — Drug Manufacturers—General company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
63/100
Risk Level
Low-Moderate
Best Action
Monitor — wait for breakout confirmation

Why: AMGN is trading near recent levels (-0.8% today). Overall, the company is reasonably solid. The long-term trend remains up. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context58
Valuation68
Trend93
Momentum59
Pullback52
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward55
Entry Timing55
Sell Risk30
Risk27

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.